Progesterone Capsule
Product Images NDC 68071-3529

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 68071-3529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph1 (Figure001)

Graph1 (Figure001)
A Kaplan-Meier probability graph showing the probability of hyperplasia over time (0 to 36+ months) for patients on medication. The graph compares three groups: Conjugated Estrogens Alone, Conjugated Estrogens Plus Micronized Progesterone (cyclical), and Placebo Only. It indicates patient counts at each time interval from 0 to 36 months.*
FDA Label Image

100 mg Capsules (Progesterone Image001 V1)

100 mg Capsules (Progesterone Image001 V1)
Label for Progesterone Capsules 100 mg, oral dosage form. The label includes a warning not to use if allergic to peanuts and instructs pharmacists to dispense with an accompanying patient information leaflet. The product is manufactured for Bionpharma Inc., Princeton, NJ, and contains 100 capsules per container. Storage instructions and dosage guidance are provided.*
FDA Label Image

100 mg Capsules (Progesterone Image001 V2)

100 mg Capsules (Progesterone Image001 V2)
Label for Progesterone Capsules 100 mg, oral dosage form, 100 count bottle. The label includes warnings for peanut allergy, storage instructions, and states the product is manufactured for Bionpharma Inc. and made in India. It also notes the pharmacist should dispense with an accompanying patient information leaflet.*
FDA Label Image

200 mg Capsules (Progesterone Image002 V1)

200 mg Capsules (Progesterone Image002 V1)
Label for Progesterone Capsules 200 mg, oral dosage form. The label includes warnings against use if allergic to peanuts and instructs pharmacists to dispense with the patient information leaflet. The package size is 100 capsules. The label also states storage instructions and is manufactured for Bionpharma Inc., Princeton, NJ. A barcode is visible with space for serialization.*
FDA Label Image

200 mg Capsules (Progesterone Image002 V2)

200 mg Capsules (Progesterone Image002 V2)
The label for PROGESTERONE Capsules 200 mg features a white background with black and red text. It includes dosage strength, allergy warning for peanuts, and dispensing instructions. The label states the product is Rx only, contains 100 capsules, and is manufactured for Bionpharma Inc. Princeton, NJ, made in India. A barcode is present on the right side.*
FDA Label Image

Chemical Structure (Structure)

Chemical Structure (Structure)
Chemical structure of progesterone depicted with labeled carbon and oxygen atoms, including ketone groups and methyl substituents, representing the molecular formula of the active ingredient progesterone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.